You have probably been there. You sit across from a provider who listens to your symptoms for ten or fifteen minutes, writes a prescription, and tells you to come back in six weeks to see how it goes. If it does not work, you try something else. And something else after that.
This is called trial and error. And for far too long it has been the standard approach to psychiatric medication management.
But here is something most providers are not telling you: there is a better way. It is called pharmacogenetic testing, and it takes the guesswork out of psychiatric prescribing entirely.
"We start where most providers stop. Pharmacogenetics is one of the reasons why."
So what exactly is pharmacogenetics?
Pharmacogenetics, sometimes called pharmacogenomics, is the study of how your genes affect the way your body processes medications. The two terms are often used interchangeably, though pharmacogenomics technically refers to the broader study of the entire genome. In clinical practice, pharmacogenetic testing is a simple cheek swab or saliva sample that analyzes specific genes responsible for metabolizing psychiatric drugs, including antidepressants, antianxiety medications, mood stabilizers, stimulants, and antipsychotics.
The results tell us something critically important: whether you are a poor metabolizer, a normal metabolizer, an intermediate metabolizer, or an ultra-rapid metabolizer of specific medications. Each of those categories changes everything about how a drug behaves in your body.
Why metabolism matters
Think of it this way. If you are an ultra-rapid metabolizer of a particular antidepressant, your body breaks it down so quickly that a standard dose is essentially gone before it ever reaches therapeutic levels. You would feel nothing, or worse, you would feel side effects without any benefit. Your provider might assume the medication is not working and increase the dose or switch to something else entirely, when in reality your genetics made that drug a poor fit from the start.
On the other end, if you are a poor metabolizer, the medication accumulates in your system faster than your body can clear it. A dose that works fine for most people becomes toxic for you. You experience intense side effects, feel worse than before, and may conclude that psychiatric medication simply does not work for you. When the truth is that the right medication at the right dose, guided by your genetics, could change everything.
The genes that matter most in psychiatric care
There are several key genes that pharmacogenetic testing looks at. The most clinically significant for psychiatric medications include:
- CYP2D6Processes a wide range of antidepressants including fluoxetine, paroxetine, and many tricyclics. Variations here are extremely common and highly impactful.
- CYP2C19Responsible for metabolizing citalopram, escitalopram, sertraline, and several others. Variations affect both efficacy and side effect risk.
- CYP3A4Involved in processing many mood stabilizers, anxiolytics, and some antipsychotics.
- SLC6A4The serotonin transporter gene. Variations here affect how your brain responds to SSRIs specifically and can predict tolerability.
- MTHFRAffects folate metabolism and neurotransmitter production. Relevant to both medication response and overall brain health.
Testing these genes does not tell us everything. But it tells us enough to make far more informed prescribing decisions than symptoms alone ever could.
What this means for your care at Aurelia
At Aurelia, pharmacogenetic testing is part of how we build your personalized treatment plan from the beginning. Before we make any prescribing decisions, we want to understand how your body is actually wired to process medication. That is not extra. That is basic due diligence that the standard psychiatric system skips because it takes more time and investment than a fifteen minute appointment allows.
What we learn from your pharmacogenetic report
Which medications are likely to work well for you based on your metabolism profile. Which medications carry a higher risk of side effects or reduced efficacy. What dose ranges are more appropriate for your genetic makeup. Whether certain medications should be avoided entirely. How your genetics interact with your current medications if you are already on something.
This is the difference between guessing and actually investigating. Between symptom management and genuine optimization.
Is pharmacogenetic testing right for everyone?
The short answer is yes. It is particularly valuable if you have tried multiple medications without success, if you have experienced significant side effects in the past, if you are currently on multiple psychiatric medications, or if you are just beginning treatment and want to start on the most informed path possible.
Your genetics do not change. So this test is something you do once and the information informs your care for life. That is a meaningful investment in your mental health.
"Your mental health is your biggest asset. It deserves more than a guess."
A note on what pharmacogenetics is not
Pharmacogenetic testing is not a crystal ball. It does not tell us which diagnosis you have or guarantee that a particular medication will work. Mental health is complex and biology is only one layer of it. At Aurelia we use pharmacogenetics alongside functional labs, nutritional assessment, nervous system evaluation, and a full picture of who you are as a person. The testing is one powerful tool in a much more comprehensive approach.
But it is a tool that conventional psychiatry routinely skips. And that gap is costing people years of their lives cycling through medications that were never a good fit to begin with.
If you have ever felt like psychiatric medication was not working for you, or like providers were just guessing, you were not wrong. The system often is. There is a more precise, more personalized, and more effective way to approach psychiatric care. Pharmacogenetics is one important part of that.
At Aurelia, we start where most providers stop.